Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a selective loss of dopaminergic neurons in the substantia nigra (SN) and subsequent depletion of dopamine in the striatum. Accumulating evidence suggests that several genetic mutations in -synuclein, parkin, DJ-1, PINK1, or LRRK2, and multiple environmental neurotoxins, such as rotenone, paraquat, dieldrin, and manganese are risk factors for PD development. 1) Even though the risk factors and pathogenic mechanisms of PD are various, the most common mechanism of dopaminergic cell death in PD is a vicious cycle of oxidative stress, mitochondrial dysfunction, and the activation of an apoptotic cascade. [2] [3] [4] 6-Hydroxydopamine (6-OHDA) is an oxidative metabolite of dopamine that induces selective death of catecholaminergic neurons, including dopaminergic neurons. It is used extensively to create in vivo and in vitro models of PD, because it generates reactive oxygen species (ROS) and reactive nitrogen species (RNS). 5) The ROS/RNS increase not only induces cellular damage directly, but also acts as an important intracellular signaling messenger targeting mitochondria and apoptosis-related cellular molecules. 6) Hence, therapeutic efforts aimed at preventing ROS induced apoptosis constitute a new approach to the prevention and treatment of the neurodegenerative process in PD. Although several synthetic chemicals, including phenolic compounds, have strong antioxidative effects, these chemicals usually have severe adverse side effects. 7) Recently, natural products exhibiting potent biological activities have received much attention because they are perceived as safe and have functions reducing the risk of PD. 8) Licorice (Glycyrrhiza uralensis) has been one of the most extensively used perennial herbs in the Middle East and Asia for thousands of years. Licorice root is used commercially as a depigmentation agent in cosmetics, and as a flavoring and sweetening agent in chewing gum, candies, and tobacco. 9) In addition, it is commonly used in oriental traditional medicine to treat digestive disorders, hepatitis, pulmonary diseases, allergies, and cardiovascular disease. 9) On the basis of these medicinal effects in the traditional system, recent studies investigated the useful pharmacological properties of licorice. Recently, an aqueous extract of licorice showed a protective effect against cadmium-induced hepatotoxicity, and memory enhancing effects in exteroceptive and interoceptive behavioral models. 10, 11) Licorice contains a large number of biological components, including flavonoids, triterpenoid saponins, isoflavonoid derivatives, and coumarins. Among these, flavonoid isoliquiritigenin (ISL) has multiple biological activities, including anti-tumor, anti-spasmodic, anti-inflammatory, and anti-oxidative effects. [12] [13] [14] Also, ISL showed protective effects in a cerebral ischemia-reperfusion injury rat model and in a methamphetamine-neurotoxicity mouse model. 15, 16) Despite these diverse pharmacological effects of ISL, its effect against the dopaminergic cell damage and pathogenesis of PD has not been studied.
In the present study we investigated the protective effects of ISL on 6-OHDA-induced apoptosis in a dopaminergic cell line, SN4741. We found for the first time that ISL-mediated neuroprotection in dopaminergic neurons was involved in attenuation of oxidative stress and mitochondria-related apoptotic cell death, and in modulation of BDNF levels and the PI3K-Akt/PKB signaling pathways.
Materials and Methods
Extraction and purification of isoliquiritigenin from licorice (Glycyrrhiza uralensis). Licorice (Glycyrrhiza uralensis) root powder was purchased from Chinese Herbs Direct (Torrance, CA). In the preparation of aqueous extract, 100 g of licorice root powder was decocted for 1 h with 1 L of reverse-osmotic water 3 times. The aqueous extract of licorice was filtered and concentrated with a vacuum rotary evaporator (Eyela, Tokyo, Japan), and then lyophilized. The lyophilized extract was dissolved in water a concentration of 200 mg/mL, applied to SephadexÔ LH-20 (1:5 Â 110 cm, Amersham Biosciences, Piscataway, NJ), and then eluted by gradient ethanol concentrations (0, 5, 20, 40, 60, 80, 100%), as described in a previous study. 13) A portion of the flavonoid-rich fractions was chromatographed on a silica gel column (1:2 Â 15 cm; Merck, Darmstadt, Germany) and further chromatographed on a reverse phase column (2:0 Â 6:0 cm, 100C 18 , Wako Pure Chemical Industries, Ltd., Osaka, Japan) to obtain isoliquritigenin, as described previously. 13 . These data coincide well with those in previous reports. 13, 15) Cell culture and treatments. Dopaminergic neuronal cell line SN4741 was cultured as described previously. 17) Cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillinstreptomycin (Gibco/Invitrogen, Carlsbad, CA) at 33 C in 5% CO 2 . SN4741 cells were cultured at a seeding density of 1 Â 10 5 cells/mL. Usually, the culture medium was changed for reduced-serum medium (0.5% FBS) before any treatment to reduce the serum effect. When indicated, SN4741 cells were pretreated with ISL for 1 h prior to treatment with 6-OHDA. To prevent direct interaction between ISL and 6-OHDA in the culture medium, at the end of ISL treatment the medium was exchanged for fresh reduced-serum medium. Cell viability was measured by 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT; Sigma, St. Louis, MO) reduction assay as described previously. 17) In a given experiment, each treatment was performed in triplicate.
Detection of apoptotic cells. To detect apoptotic cells, nuclear staining with 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; Sigma) was performed. SN4741 cells were exposed to 6-OHDA for 24 h with and without pretreatment with ISL and fixed with 1% paraformaldehyde in PBS over 30 min at room temperature (RT). After fixation, the cells were washed twice with PBS and then permeated with ice-cold ethanol for 5 min at RT. After three rounds of washing with PBS, the fixed cells were stained with DAPI (300 nM) over 5 min at RT in the dark. After an additional three rounds of washing with PBS, the cells were examined by fluorescent microscopy (IX71, Olympus, Tokyo). The percentage of apoptotic cells, which coincided with morphological criteria of apoptosis such as bright condensed and fragmented nuclei, was calculated as the ratio of apoptotic nuclei to the total number of nuclei. At least four randomly chosen fields were counted in a given experiment.
Caspase-3 enzymatic activity. Caspase-3 activity in cells treated for 0, 6, 12, 18, and 24 h with 6-OHDA in the presence and the absence of ISL was measured by colorimetric assay using caspase 3 substrate Ac-DEVD-pNA (Sigma). Cell lysates were prepared from 5 Â 10 5 cells in cold lysis buffer (50 mM HEPES, pH 7.4, 1 mM DTT, 0.1 mM EDTA, 0.1% CHAPS), incubated for 5 min on ice, and then clarified by centrifugation at 10;000 Â g at 4 C for 10 min. Protein samples (10 mg) were incubated at 25 C with 200 mM of caspase 3 substrate. The formation of p-nitroanilide (pNA) from the reaction was measured over 60 min using a microplate reader (VersaMax, Molecular Devices, Sunnyvale, CA) at a wavelength of 405 nm. Activity was calculated as picomoles of substrate hydrolyzed per min.
Measurement of brain-derived neurotrophic factor (BDNF) release. Measurement of changes in BDNF production and release was done by enzyme-linked immunosorbent assay (ELISA). SN4741 cells were stabilized for 24 h in a culture medium with 10% FBS, and then the medium was replaced with serum-deprived medium. After 24 h treatment with ISL (1 mM) and 6-OHDA (50 mM), the level of BDNF released from the cells into the culture medium was measured by the Promega BDNF Emax ImmunoAssay Systems (Promega, Madison, WI). The absorbance was measured at 450 nm using an automatic ELISA plate reader (VersaMax, Molecular Devices).
Measurement of intracellular reactive oxygen species (ROS) accumulation. Intracellular ROS formation was examined using 2 0 ,7 0 -dichlorodihydrofluorescein diacetate (H 2 DCFDA; Molecular Probes/ Invitrogen, Carlsbad, CA). SN4741 cells were treated with 6-OHDA (50 mM) with and without ISL (1 mM) at various time points (0.5, 1, 3, 6, and 12 h). After washing with Hank's balanced salt solution (HBSS), the cells were incubated with 10 mM H 2 DCFDA at 37 C for 30 min. After removal of excess H 2 DCFDA by washing twice with HBSS, the cellular fluorescence of dichlorofluorescein (DCF) was measured at 485 nm excitation and 520 nm emission in a fluorescence multimode microplate reader (Infinite 200; Tecan, Grödig, Austria).
Measurement of nitric oxide (NO).
The production of NO was determined by measuring accumulated nitrite, a stable oxidation end product of NO, in the culture medium. The cell culture supernatants (each 100 mL) were collected after chemical treatment for 24 h, and were mixed with an equal volume of Griess reagent (a 1:1 mixture of 1% sulfanilamide in 5% phosphoric acid and 0.1% naphthylethylendiamine dihydrochloride in water). After 10 min of incubation under reduced light at RT, the absorbance at 550 nm was measured by microplate reader (VersaMax, Molecular Devices). Sodium nitrite (NaNO 2 ) was used as standard to calculate the nitrite concentration.
Measurement of mitochondrial membrane potential (MMP).
Mitochondrial membrane potential (ÁÉm) was measured using 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolocarbocyanine iodide (JC-1; Sigma), a lipophilic cationic fluorescence dye. JC-1 can enter the mitochondria selectively and accumulate to form red fluorescent Jaggregates in healthy cells with intact mitochondrial membrane potential, but it exists as green fluorescent monomers that do not accumulate within the mitochondria in damaged cells with collapsed mitochondrial membrane potential. Mitochondria membrane damage is indicated by a decrease in the red-to-green fluorescence ratio. Following 12 h of treatment with 6-OHDA (50 mM) with or without ISL (1 mM), SN4741 cells were incubated with 10 mg/mL of JC-1 at 37 C for 20 min. After 3 rounds of washing with PBS, the fluorescence intensity was measured at red (535 nm excitation/590 nm emission) and green (485 nm excitation/535 nm emission) with a fluorescence multimode microplate reader (Infinite 200; Tecan). The result was calculated as the ratio of red to green fluorescence, and was expressed as the percentage over control.
Immunoblot analysis. To isolate whole-cell proteins, SN4741 cells grown under various experimental conditions were washed twice with PBS and then lysed with 100 mL per 1 Â 10 6 cells of RIPA buffer (PBS, 1% NP40, 0.5% Na deoxycholate, 0.1% SDS, 0.1 mg/mL of PMSF, 30 mg/mL of aprotinin, 1 mM Na 3 VO 4 ). To detect cytochrome c in the mitochondria and cytosol, the cells were lysed with a mitochondrial/ cytosolic fraction kit (Biovision, Mountain View, CA) following the manufacturer's protocol. The protein concentration was determined with a BCA protein assay kit (BioRad, Hercules, CA), using bovine serum albumin as standard. Protein samples (30 mg) were separated by 10-15% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and then transferred onto polyvinylidine difluoride (PVDF) membranes. After transfer, the membranes were blocked in fresh blocking buffer (0.1% Tween 20 in Tris-buffered saline, pH 7.4, containing 5% nonfat dry milk) for 2 h at RT. They were incubated overnight at 4 C with the following primary antibodies at a dilution of 1/1,000: Bax, cytochrome c (Santa Cruz Biotechnology, Santa Cruz, CA), p-JNK, p-p38 (Cell Signaling Technology, Beverly, MA) or 1/ 4,000: Bcl-2, Actin (Santa Cruz Biotechnology). After 3 rounds of washing with TBST buffer (0.1% Tween 20 in Tris-buffered saline, pH 7.4), the membranes were incubated with HRP-conjugated secondary antibody (1/2,000 dilution) for 2 h at RT. Signals were detected by the enhanced chemiluminescence (ECL) system (GE Healthcare, Piscataway, NJ). Protein bands were quantified by densitometric analysis.
Statistical analysis. Data were expressed as mean AE SEM. Statistical analysis was done using the SPSS 12.0 software package. Differences were analyzed by one-way factorial analysis of variance (ANOVA), followed by Student's t-test. A p value of less than 0.05 was considered statistically significant.
Results

Protective effect of ISL against 6-OHDA-induced neurotoxicity
The dopaminergic neuronal cell line SN4741 is used recently to study dopaminergic pathogenesis, because it expresses many of the characteristic features of dopaminergic neurons, including tyrosine hydroxylase (TH) and dopamine transporter expression and susceptibility to MPP þ toxicity, which is attenuated by exogenous BDNF. 17) To determine whether ISL protects dopaminergic neurons from 6-OHDA-induced cytotoxicity, SN4741 cells were adopted as a model system. The effect of ISL on 6-OHDA-induced SN4741 cell death was assessed by XTT assay. Initial studies were performed to evaluate the cytotoxic response of SN4741 cells to ISL. SN4741 cells were treated with various concentrations of ISL (0.1, 0.5, 1, and 2 mM) over 24 h. As shown in Fig. 1B , ISL treatment with 1 mM and lower concentrations did not affect the cell viability of SN4741 cells. Hence we did all subsequent experiments using 1 mM of ISL.
Previous reports indicate that various cell lines were treated with 6-OHDA at concentrations ranging from 25 mM to 300 mM according to the initial seeding density and the treatment period. 18, 19) Under our experimental conditions, 6-OHDA caused cytotoxicity in SN4741 cells at concentrations of 25-100 mM after 24 h of treatment (Fig. 1C) , and 50 mM 6-OHDA induced approximately 50% cell loss. Based on this result, 50 mM 6-OHDA was chosen for subsequent experiments. To investigate the effect of ISL on 6-OHDA-induced dopaminergic cell death, SN4741 cells were pretreated with 1 mM ISL for 1 h, followed by 10-100 mM 6-OHDA treatment for 24 h. As shown in Fig. 1C, 6 -OHDAinduced cell loss was significantly attenuated by ISL treatment. Especially, pretreatment with 1 mM ISL produced almost complete blocking of 25 mM and of 50 mM 6-OHDA-induced cell death.
Effects of ISL on apoptosis rate and BDNF level
We investigated the effects of ISL on 6-OHDAinduced apoptotic characteristics, including nuclear morphology changes and caspase 3 activation in SN4741 cells. Nuclear morphological changes were examined by DAPI staining. Although the nuclear morphology of the cells exposed to ISL and the untreated control cells was intact, 50 mM 6-OHDA treatment alone for 24 h induced obvious nuclear condensation and fragmentation, characteristics of apoptosis, but ISL pretreatment significantly inhibited 6-OHDA-induced nuclear damage (Fig. 2A) . As quantified in Fig. 2B , the level of apoptotic nuclei in the 6-OHDA treated cells was 15:7 AE 1:5%, but ISL pretreatment prior to exposure to 6-OHDA reduced apoptotic rate to 5:1 AE 1:2%.
Next we examined caspase 3 activity as another marker of apoptosis. Caspase 3 activity was strongly enhanced after 12 h (by 1.31-fold), 18 h (1.8-fold), and 24 h (2.89-fold) of exposure to 6-OHDA. In contrast, pretreatment with ISL reduced 6-OHDA-induced caspase 3 activity at each time point (Fig. 2C) . In accordance with the viability results, ISL strongly reduced 6-OHDA-induced apoptotic nuclear morphology formation and caspase 3 activity. These results confirm that ISL protects dopaminergic cells via antiapoptotic pathway at least in part. Cell viability was determined by XTT reduction assay, as described in ''Materials and Methods.'' A, Chemical structure of isoliquritigenin (ISL). B, Indicated concentrations of ISL were exposed to SN4741 cells for 24 h, and then cell viability was expressed as a percentage of untreated control (Con). C, Cells were pretreated with 1 mM ISL for 1 h and incubated for 24 h with various concentrations of 6-OHDA (10, 25, 50, and 100 mM). The cell viability of ISL pretreated group was compared with that of the 6-OHDA alone treated group at each concentration. Data are mean AE SEM for three independent experiments in triplicate. The asterisk represents statistical significance.
Ã p < 0:01 as compared with untreated control.
# p < 0:01 as compared with 6-OHDA alone.
BDNF has been found to be secreted from SN4741 cells with potent neurotrophic effects on dopaminergic neuronal survival and maturation. 20, 21) To investigate the BDNF level after treatment with ISL and 6-OHDA in SN4741 cells, ELISA assay was performed using Promega's Emax ImmunoAssay System. As shown in Fig. 3, 6 -OHDA inhibited BDNF release by 37% at 24 h in SN4741 cells. However, ISL itself caused a statistically significant increase in BDNF (27% at 24 h), and ISL pretreatment significantly attenuated 6-OHDA-induced BDNF depletion. This suggests that ISL might occasion BDNF-evoked neuroprotection in dopaminergic neurons.
Inhibitory effects of ISL on ROS and NO elevation by 6-OHDA in dopaminergic cells
Dopaminergic neurons have been found to be particularly vulnerable to oxidative stress. 22) We determined the changes of ROS and NO levels in SN4741 cells, since elevation of these oxidative species usually initiates a neurotoxic cascade induced by 6-OHDA. To examine intracellular ROS formation and NO release, we used a fluorescent sensitive probe H 2 DCHDA and Griess reagent respectively. Treatment with 6-OHDA (50 mM) induced time-dependent intracellular ROS generation in SN4741 cells, with the largest increase (1.99-fold) at the 3-h time point, whereas pretreatment with ISL (1 mM) effectively lowered the ROS level at each time point (Fig. 4A) . Additionally, treatment with 6-OHDA for 24 h increased NO production up to 3.38-fold as compared with the control group, while pretreatment with ISL significantly reduced NO production, to 0.41-fold as compared with the 6-OHDA treated group.
Effect of ISL on mitochondrial membrane potential (MMP)
It has been found that mitochondrial dysfunction with a loss of MMP (ÁÉm) is a critical event in the degeneration of dopaminergic neurons. 23) To identify the changes in MMP in SN4741 cells, mitochondria-specific lipophilic cationic fluorescent dye JC-1 was used. Control cells having intact MMP showed intense red fluorescence inside the mitochondria, but exposure of the cells to 6-OHDA (50 mM) for 12 h markedly decreased red fluorescence with concomitantly increased green fluorescence. Quantification of JC-1 fluorescence revealed a significant decrease in the ratio of red to green fluorescence intensity, an indication of MMP loss, in the 6-OHDA treated cells as compared to the control cells, and pretreatment with ISL (1 mM) markedly reduced 6-OHDA-induced MMP loss in SN4741 cells (Fig. 5) .
Inhibitory effects of ISL on apoptotic proteins expression by 6-OHDA in dopaminergic cells
It has been found that several mitochondria-associated proteins (including Bcl-2, Bax, and cytochrome c) and MAP kinases (including JNK and p38) play critical roles in the apoptotic cell death pathway. 18) We examined to determine whether the expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax is regulated by ISL in SN4741 cells. As shown in Fig. 6A , treatment with 50 mM 6-OHDA significantly decreased Bcl-2 and increased Bax protein expression, but pretreatment with ISL (1 mM) almost completely prevented these changes in , 1 h) followed by 6-OHDA (50 mM, 24 h). Arrows indicate chromatin condensation, reduced nuclei, and fragmented nuclei of typical apoptotic cells. Scale bar indicates 10 mm. B, Apoptosis rate was calculated as the ratio of apoptotic nuclei to total nuclei. C, The activation of caspase 3 was measured using a specific substrate, Ac-DEVD-pNA, at various time points. Activity was calculated as picomoles of substrate hydrolyzed/min/mg of protein. All values are mean AE SEM for three independent experiments. Ã p < 0:01 as compared with untreated control.
# p < 0:01 as compared with 6-OHDA treatment alone. SN4741 cells were pretreated with ISL (1 mM) for 1 h and exposed to 6-OHDA (50 mM) for 24 h. The amount of BDNF in the cellconditioned media was quantified by BDNF ELISA assay. All values are mean AE SEM for four independent experiments. Ã p < 0:05 as compared with untreated control.
Bcl-2/Bax expression in SN4741 cells. Although 6-OHDA significantly reduced the Bcl-2/Bax ratio, to 32% of control, ISL pretreatment maintained the Bcl-2/ Bax ratio at 89% of control (Fig. 6B) . In addition, 6-OHDA induced a significant increase in the release of cytochrome c from the mitochondria to the cytosol (1.54-fold of control), but pretreatment with ISL significantly suppressed the release of cytochrome c to the cytosol (1.14-fold of control). To examine the activation of JNK and p38 MAP kinase under our experimental conditions, the levels of phosphorylated JNK and p38 were assessed by immunoblot analysis. When cells were exposed to 50 mM 6-OHDA, the levels of phosphorylated JNK and phosphorylated p38 increased markedly, to 1.99-fold and 2.11-fold respectively, as compared to the control cells (Fig. 6) . Pretreatment with ISL entirely prevented the JNK phosphorylation induced by 6-OHDA, but 6-OHDA-induced phosphorylation of p38 was partially inhibited by ISL (it decreased from 2.11-fold to 1.77-fold).
Effects of selective inhibitors of PI3K and Akt/PKB signal pathways on ISL-mediated dopaminergic cell survival against 6-OHDA neurotoxicity
To elucidate further which intracellular signaling pathways are involved in ISL-mediated neuroprotection, a pharmacological approach was used with specific inhibitors of various signaling molecules. As shown in A, The expression of Bcl-2, Bax, cytosol and mitochondria cytochrome c, phospho-JNK, and phosph-p38 was detected by immunoblot using specific antibodies. Anti-actin was used for normalization. SN4741 cells were pretreated with ISL (1 mM) for 1 h, and then exposed to 6-OHDA (50 mM) for 6 h (for the analysis of p-JNK and p-p38) or 12 h (for the analysis of Bcl-2, Bax, and cytochrome c). B, The intensity of bands was estimated by densitometric analysis, and was expressed as fold changes relative to control. Data represent AE SEM for three independent experiments.
Ã p < 0:05 as compared with untreated control. # p < 0:01 as compared with 6-OHDA alone. A, SN4741 cells were treated with ISL (1 mM) for 1 h, followed by 6-OHDA (50 mM) treatment for a maximum of 12 h. Then the cells were incubated with the H 2 DCFDA fluorescent dye for 30 min. ROS generation was determined by measuring DCF-derived fluorescence intensity. B, The amount of NO production was determined by the nitrite level in the supernatant using the Griess reaction after 6-OHDA treatment for 24 h. Data are mean AE SEM for three independent experiments in triplicate.
Ã p < 0:01 as compared with untreated control. # p < 0:01 as compared with 6-OHDA treatment alone. Fig. 7, LY294002 (the PI3K inhibitor) and triciribine (the Akt/PKB inhibitor) significantly suppressed the cytoprotective effect of ISL. On the contrary, SB203580 (the p38 MAPK inhibitor) and SP600125 (the JNK inhibitor) maintained cell viability over the control level and showed obviously enhanced viability than that of the ISL/6-OHDA treated condition. PD98059 (the Erk1/2 inhibitor), PKI (the PKA inhibitor), and Gö6983 (the PKC inhibitor) did not affect ISL-mediated protection. All these inhibitors themselves had no obvious effects on cell viability in SN4741 cells. From these results, we concluded that the JNK and p38 MAPK pathways are associated with 6-OHDA-induced cell death, and that ISL exerts a neuroprotective effect at least in part through the PI3K-Akt/PKB pathway in SN4741 cells.
Discussion
Even though multiple environmental and genetic factors can be causes of PD, previous studies strongly suggest that oxidative stress and mitochondrial dysfunction are common pathogenic mechanisms in PD. 1, 17) Recently, neuroprotection using naturally occurring components as a therapeutic strategy for PD has received much attention, because the natural products are safe and might be preventive therapeutic agents against PD-related neurotoxins.
6-OHDA is one of the most selective catecholaminergic neurotoxins, and several studies have reported that it has been used as in vivo and in vitro experimental model of PD. 18, 24) Exposure to 6-OHDA induced DNA damage, mitochondria dysfunction, and apoptotic cell death. 25, 26) In agreement with previous studies, our results indicate dose-dependent viability loss (Fig. 1) and essential morphologic forms of apoptosis with caspase 3 activation (Fig. 2) under treatment with 6-OHDA in SN4741 cells. ISL pretreatment greatly decreased cell viability loss and significantly suppressed nuclear condensation, fragmentation, and caspase 3 activation (Figs. 1 and 2) . These results strongly suggest that ISL protects SN4741 cells from 6-OHDA-induced apoptotic cell death. To our knowledge, this is the first evidence of the anti-apoptotic effects of the licorice component in dopaminergic neuronal cells.
BDNF acts as a specific neurotrophic factor that increases the survival and the morphology differentiation of dopaminergic neurons. 21) When the endogenous release of BDNF was neutralized by a specific antibody, dopaminergic neuronal cell death was significantly enhanced. 27) Our previous results indicate that some molecules, including cholecystokinin, glutamate, fibroblast growth factor 8b (FGF8b), epidermal growth factor (EGF), bone morphogenic protein 4 (BMP4), dibutyryl cGMP, okadaic acid, 3-isobutyl-1-methylxanthine (IBMX), dipyridamole, and salicylic acid, promoted BDNF production in dopaminergic neurons. 20) However, free-radical generators, H 2 O 2 and SNP, significantly suppressed the amount of BDNF release in SN4741 cells. 28) In accordance with previous findings, this study indicates that 6-OHDA, generating NO and other free radicals, induced significant decreases in BDNF release from SN4741 cells (Fig. 3) . At the same time, we found for the first time that ISL significantly enhanced BDNF production and lessened the downregulation of BDNF release by 6-OHDA in SN4741 cells (Fig. 3) . This suggests that ISL protects SN4741 cells from 6-OHDA by delaying or preventing further BDNF loss.
It has been proposed that 6-OHDA undergoes spontaneous auto-oxidation and generates RNS, such as NO and peroxynitrite, and ROS, including the superoxide anion, the hydroxyl radical, and hydrogen peroxide. 19) In this study, we found that treatment of SN4741 cells with 6-OHDA led to early and robust generation of intracellular ROS and increased NO production (Fig. 4) . In addition, we found that ISL pretreatment almost completely attenuated the ROS and NO production induced by 6-OHDA. When our results were analyzed in detail, the 1 mM ISL-mediated protection ratios were correlated with the levels of ROS suppression and NO attenuation. However, it is at present unclear whether ISL scavenges intracellular ROS and NO directly. Oxidative stress perturbs mitochondrial function, which leads to apoptosis. In addition, mitochondria are the primary source of cellular oxidants.
3) ROS production induced by 6-OHDA is directly related to the collapse of MMP. 29) Using mitochondriaspecific fluorescent dye JC-1, we found that 6-OHDA evoked a MMP decrease in, indicating mitochondrial dysfunction (Fig. 5) . However, ISL pretreatment effectively suppressed MMP dissipation.
Bcl-2 family members and cytochrome c are involved in mitochondrial membrane dysfunction and the progress of apoptotic cell death. An anti-apoptotic protein, Bcl-2, acts as a molecular stabilizer for mitochondrial membrane permeability and suppresses the release of cytochrome c from the mitochondria. However, proapoptotic Bcl-2 family members, such as Bax, can translocate to the mitochondrial membrane by means of apoptotic inducers, including 6-OHDA, and subse- SN4741 cells were pretreated with 2 mM LY294002 (PI3K inhibitor), 1 mM Triciribine (Akt/PKB inhibitor), 2 mM SB203580 (p38 MAPK inhibitor), 2 mM SP600125 (JNK inhibitor), 2 mM PD98059 (Erk1/2 inhibitor), 1 mM PKI (PKA inhibitor), or 2 mM Gö6983 (PKC inhibitor) for 1 h, and then treated with 1 mM ISL for 1 h before exposure to 50 mM 6-OHDA. Cell viability was assessed by XTT reduction assay 24 h after treatment with 6-OHDA. PI3K inhibitor LY294002 and Akt/PKB inhibitor Triciribine inhibited the protective effect of ISL against 6-OHDA-induced cytotoxicity. Data are mean AE SEM for three independent experiments in triplicate. Ã p < 0:01 as compared with untreated control.
ÃÃ p < 0:01 as compared with ISL plus 6-OHDA treated condition without inhibitors. Abbreviations: LY, LY294002; TR, Triciribine; SB, SB203580; SP, SP600125; PD, PD98059; GO, Gö6983.
quently induce cytochrome c release from the mitochondria into the cytosol. 30) After it translocates to the cytosol, cytochrome c can activate the caspases responsible for apoptosis. In agreement with previous studies, our results indicate a remarkable decrease in the Bcl-2/ Bax ratio and increases in cytochrome c in the cytosol after 6-OHDA treatment (Fig. 6 ), but these effects of 6-OHDA were significantly lessened by pretreatment with ISL. Taken together, these results strongly suggest that ISL protected the dopaminergic cells against 6-OHDA-induced apoptosis and against the modulation of mitochondria-related proteins.
Accumulating evidence indicates that the ROS increase not only inflicts direct cellular damage, but also modulates MAP kinases and other protein phosphorylation-dependent signaling cascades. 31, 32) MAP kinase subfamilies, including Erk1/2, JNK, p38 MAPK, and Erk5, have been suggested to play prominent roles in the regulation of neuronal cell survival and death. 31) Among these, the phosphorylated forms of JNK and p38 MAPK were highly elevated in the postmortem brains of PD patients. 33) In addition, JNK and p38 MAPK signaling pathways have been consistently suggested to be key factors in 6-OHDA-induced apoptosis, 34, 35) but there is a discrepancy as to the pathological role of Erk1/2. Some reports suggest that Erk1/2 protects neurons against 6-OHDA toxicity, and others that the Erk1/2 pathway is necessary for 6-OHDA-induced apoptosis. 35, 36) Our results indicate that ISL preferentially suppressed the activation of JNK and p38 MAPK induced by 6-OHDA in the SN4741 cells (Fig. 6) . Furthermore, when cells were pretreated with JNK inhibitor (SP600125) or p38 inhibitor (SB203580), the protective effect of ISL against 6-OHDA was enhanced (Fig. 7) . This means that both p38 and JNK acted as death molecules, while ISL effectively attenuated p38 and JNK. However, ISL did not significantly change the level of Erk1/2, which was slightly elevated by 6-OHDA (data not shown). These results suggest that ISL protects SN4741 cells through attenuation of both JNK and p38 MAPK, whereas the Erk1/2 signaling pathway is not affected by ISL in this cell line. In addition to the MAPKs pathway, other signaling pathways, including PI3K-Akt/PKB, PKA, and PKC, are thought to be involved in neuronal survival. 18, 19, 37) In the experiments using pharmacological inhibitors of MAPKs, PI3K, Akt/PKB, PKA, and PKC, we found that the PI3K and Akt/PKB pathways played crucial roles in ISL-mediated neuroprotection (Fig. 7) . It has been found that PI3K is upstream of the serine/threonine protein kinase Akt/ PKB, and PI3K-Akt/PKB signaling pathway is considered to be a survival pathway. 19, 37) Akt/PKB mediates the cell survival signal mainly through direct or indirect induction of anti-apoptotic Bcl-2 and blocking of the pro-apoptotic function of Bad. [38] [39] [40] In conclusion, the present study indicates for the first time that ISL can protect dopaminergic neuronal cells. ISL significantly suppressed 6-OHDA-induced apoptosis, accompanied by suppression of the generation of ROS and NO, activation of JNK and p38 MAPK, decreases in the Bcl-2/Bax ratio, MMP, and BDNF, the release of cytochrome c, and the activation of caspase 3. In addition, it protected SN4741 cells through the PI3K-Akt/PKB signaling pathways, probably by modulating Bcl-2 and other mitochondria-related apoptosis proteins. It is reasonable to conclude that the protective effect of ISL is due to suppression of mitochondrial dysfunctionmediated apoptosis.
